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Abstract
Background: Only controlled blocks are capable of confirming the zygapophysial joints (ZJ) as the
pain generator in LBP patients. However, previous workers have found that a cluster of clinical
signs ("Revel's criteria"), may be valuable in predicting the results of an initial screening ZJ block. It
was suggested that these clinical findings are unsuitable for diagnosis, but may be of value in
selecting patients for diagnostic blocks of the lumbar ZJ's. To constitute evidence in favour of a
clinical management strategy, these results need confirmation. This study evaluates the utility of
'Revel's criteria' as a screening tool for selection of chronic low back pain patients for controlled
ZJ diagnostic blocks.
Methods: This study utilized a prospective blinded concurrent reference standard related validity
design. Consecutive chronic LBP patients completed pain drawings, psychosocial distress and
disability questionnaires, received a clinical examination and lumbar zygapophysial blocks. Two
reference standards were evaluated simultaneously: 1. 75% reduction of pain on a visual analogue
scale (replication of previous work), and 2. abolition of the dominant or primary pain. Using "Revel's
criteria" as predictors, logistic regression analyses were used to test the model. Estimates of
sensitivity, specificity, predictive values and likelihood ratios for selected variables were calculated
for the two proposed clinical strategies.
Results: Earlier results were not replicated. Sensitivity of "Revel's criteria" was low sensitivity
(<17%), and specificity high (approximately 90%). Absence of pain with cough or sneeze just
reached significance (p = 0.05) within one model.
Conclusions: "Revel's criteria" are unsuitable as a clinical screening test to select chronic LBP
patients for initial ZJ blocks. However, the criteria may have use in identifying a small subset (11%)
of patients likely to respond to the initial block (specificity 93%).
Background
It is estimated that 15 – 40% of chronic low back pain
patients have pain arising from the lumbar zygapophysial
joints (ZJ)[1,2]. Previous studies have indicated that his-
torical and physical examination findings cannot predict
results from diagnostic ZJ blocks [1-6]. A specific sequence
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of injections of local anesthetic under fluoroscopic guid-
ance into the joint space or targeting the medial branches
of the dorsal rami, are reference standards for diagnosis.
For the ZJ to be considered the sole source of pain, there
must be a total or near total pain ablation for a time con-
sistent with the known properties of the anesthetic
agent[7,8]. In a recent study by Revel M et al (1998), the
authors found that a cluster of seven items, (hereinafter
called Revel's criteria) were shown to be of value in pre-
dicting a 75% reduction of pain following a single intra-
articular anesthetic injection into the ZJs. The items in the
cluster are: age over 65 years, pain well relieved by recum-
bency, no exacerbation of pain with: coughing and sneez-
ing, forward flexion, extension, rising from flexion and
the extension-rotation test[9]. These authors suggested
two clinical strategies: Strategy 1 consists of five or more
items being true. Strategy 2 is the same except that one of
the true statements must be 'pain well relieved by recum-
bency'. Estimated sensitivities and specificities for strate-
gies 1 and 2 were 100/92%, and 66/80% respectively. A
subsequent study of 200 consecutive patients using dou-
ble blocks failed to confirm these findings[6].
Because prognosis for acute low back is good, invasive and
expensive and invasive diagnostic testing cannot be justi-
fied. However, persistent disabling pain needs more
intensive investigation in order to determine appropriate
management strategies. Back pain of ZJ origin may be
treated using intra-articular steroid injection[7,10]., or
radio frequency neurotomy [11-14]. However, the low
prevalence of the condition dictates that a clinical selec-
tion process capable of identifying patients unlikely to
respond to the initial screening diagnostic block is desira-
ble. Patients with a low probability of a positive anesthetic
response need not be subjected to the screening block and
the tissue origin of pain should be sought elsewhere.
Revel's criteria are currently the only documented clinical
means by which response to an initial screening block
may be predicted, but it remains a provisional finding
only, until further research confirms the previous
findings.
The current study objectives were to estimate the predic-
tive value of the two clinical strategies of Revel et al
(1998), using similar measurement parameters (75%
reduction in pain VAS after ZJ block), and apply alterna-
tive analytic methods to explore any potential utility of
the variables used.
Methods
Design
This study utilized a prospective, blinded, concurrent, ref-
erence standard-related validity design with intra-articular
ZJ or medial branch blocks as the reference standard
against which clinical variables were compared. Local
Institutional Review Board approval was granted at the
beginning of the study. A 75% or more reduction in pain
following ZJ block on pain VAS was designated as refer-
ence standard A, the same standard used by Revel et al
(1998). Based on pain drawings and patient self-report,
complete abolition of the patient's primary or dominant
pain was designated as reference standard B. Dominant
pain location was acquired by pain drawing and direct
questioning, and documented prior to clinical examina-
tion and diagnostic injection in a prospective manner.
Post injection dominant pain location was acquired by
reference to pain drawings and direct questioning also.
Patients
Patients with low back pain with or without lower extrem-
ity symptoms, referred to a private radiology practice in
New Orleans, USA specializing in the diagnosis of spinal
pain, were invited to participate in the study. Patients
receiving ZJ blocks were either referred specifically for that
procedure or had the procedure included in their radiol-
ogy examination based on pre-injection clinical evalua-
tion by the injectionist (CA). Between May 2001 and
October 2002, physical therapists attended the clinic in
blocks that ranged from 4 to 8 weeks (ML) and examined
patients. Normal scheduling was not affected by the pres-
ence of the visiting therapists, so patients were consecutive
during these periods. All patients had undergone imaging
studies prior to referral from a variety of medical and par-
amedical practitioners. Some were self-referred.
Patients were excluded from the study if they were unwill-
ing to participate, were too frail to tolerate a physical
examination, or were deemed by any member of the clinic
team to be unable to comprehend the study procedure.
Prior to the formal clinical examination, clinic staff
recorded basic demographic and medical data.
Measurements
Pain
100 mm visual analog scales (VAS) scales for current, best
and worst pain. A current pain VAS was repeated after the
clinical examination and following ZJ blocks. The 23-
point Roland-Morris Disability Questionnaire [15] was
completed to evaluate disability, and psychosocial dis-
tress estimated using the Zung Depression Index[16], the
Modified Somatic Perception Questionnaire[17] and the
Distress Risk Assessment Method (DRAM) [18].
The physical examination
History taking and a structured physical examination were
carried out by a physical therapist with 30 years of clinical
experience as a manipulative therapist (ML). Some
patients were examined by a physical therapist with 17
years experience (SBY). The clinical examination occupied
30 to 60 minutes and included many tests besides thoseBMC Musculoskeletal Disorders 2004, 5:43 http://www.biomedcentral.com/1471-2474/5/43
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necessary for the current analysis, as part of a larger
project. Inconclusive findings or incomplete examina-
tions were documented. The physical examination
included a visual assessment of range of motion, record-
ing anatomical location of dominant pain, nerve tension
tests, key muscle strength tests, tendon reflex tests, light
touch sensitivity, a McKenzie[19] styled examination and
where possible, Waddell's tests for signs of inappropriate
pain behaviour[20]. The data for Revel's criteria[9]were
obtained in a prospective and systematic manner using
standardized language and terminology. The four physical
tests that form part of the criteria are depicted in Figure 1.
(see file Figure 1 Revels criteria.png)
Radiology examination
Prior to ZJ blocks, the radiologist reviewed case notes and
imaging studies, and conducted a physical examination
that guided the type of diagnostic procedure to be
employed and the target structures. Intra-articular ZJ joint
injection or MBB using standard technique[5] was carried
out by an interventional radiologist (CA) with 20 years
experience, or by an injectionist under his guidance.
Patient pain responses to injections were recorded as 0.5
cc Lidocaine 2% was slowly injected into the target joint
or at medial branch targets. Pain intensity 100 mm VAS's
were recorded 30 to 45 minutes post procedure, then
hourly in a pain journal for eight hours post-injection.
Reference standards A and B were evaluated. A positive
anesthetic response was recorded if reduction or abolition
of pain lasted the known duration of lidocaine, about one
and a half hours. Where appropriate and possible, posi-
tive responders were rescheduled for confirmatory blocks
using bupivacaine 0.75%. A ZJ source of pain was con-
firmed if a confirmatory block was positive and relief of
pain lasted for at least four hours. Some patients received
ZJ blocks and sacroiliac joint injections during the same
session. If the combined block was positive, the patient
was scheduled to return for confirmatory blocks to iden-
tify which structure was responsible for the effect. If the
combined block produced less than 75% reduction in
pain, a negative ZJ block was recorded.
Blinding
Physical therapists conducting the clinical examination
were blinded to the results of previous imaging studies
and diagnostic injections, the Roland, Zung and MSPQ
questionnaires. The injectionist was blinded to the results
of the physical therapy examination and diagnostic
conclusions.
Data analysis
Basic statistical values for demographic variables and
regression analyses were calculated using statistics soft-
ware (Minitab version 13.31 © Minitab Inc 2000). Differ-
ences between included and excluded patients were
evaluated with the student's t, chi square, and Kruskal-
Wallis tests where appropriate. Significance for differences
was set at p < 0.05.
Calculations of sensitivity, specificity, predictive values
and likelihood ratios with 95% confidence intervals were
performed using Confidence Interval Analysis software ©
Bryant T.N. 2000[21].
Results
Initial ZJ blocks were carried out on 151 chronic low back
pain patients. Thirty-four patients were excluded from
analysis as they received another intervention in the same
procedure session and did not return for differentiating
and confirmatory blocks. One case was excluded through
incomplete data on Revel's criteria. Following ZJ block, 27
of 116 patients satisfied reference standard A. Data
required for determination of Reference standard B were
missing for five of the 116 cases. Eighteen of these 111
patients satisfied reference standard B. Table 1 contains
demographic and other descriptive characteristics with
comparisons between included and excluded patients.
Included patients had longer time off work than excluded
patients (mean 55 versus 99 weeks) but otherwise had
similar characteristics.
In specifically evaluating Revel's criteria against reference
standard A, logistic regression failed to achieve signifi-
cance as a model (n = 108, p = 0.46). Two variables;
"absence of pain with coughing and sneezing" and "no
exacerbation of pain rising from flexion", showed a trend
towards significance as predictors within the model (p =
0.07).
The four physical examination components of Revel's criteria  for lumbar zygapophysial joint pain Figure 1
The four physical examination components of Revel's criteria 
for lumbar zygapophysial joint pain: standing flexion, return-
ing from standing flexion, standing extension, the extension 
rotation test.BMC Musculoskeletal Disorders 2004, 5:43 http://www.biomedcentral.com/1471-2474/5/43
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Using Revel's criteria within a logistic regression with ref-
erence standard B as the response variable, a strong trend
towards significance was reached (n = 100, p = 0.06). One
component variable (age over 65) individually reached
significance within the model: (p = 0.004, odds ratio 16.1
with 95% confidence intervals of 2.4 and 107.8). In the
whole sample 12.5% were aged over 65 years whereas of
the 19 positive responders six were over 65 years (31.6%).
The same patients satisfied both strategies of Revel et al.
Estimated sensitivity, specificity, predictive values and
positive likelihood ratios for both strategies of Revel et al
Table 1: Basic demographic data results for chronic LBP patients receiving screening ZJ blocks
All patients (n = 151) Excluded patients (n = 35) Included patients (n = 116) Significance
Variable Mean Median STD Mean Median STD Mean Median STD p value
Age (years) 44.3 43.0 13.2 48.03 48.0 14.3 43.2 41.5 12.6 0.09
Duration of current 
symptoms (weeks)
147.1 91.0 170.2 103.7 74.0 93.5 160.2 104.0 186.2 0.08
Time off work (weeks) 89.5 (n = 69) 74.0 82.4 55.4 (n = 15) 56.0 41.3 99.0 (n = 54) 82.0 88.6 0.04*
VAS (today) 55.9 61.0 24.6 50.8 53.0 27.0 57.4 62.0 23.7 0.24
VAS (at best) 30.3 27.0 22.5 24.6 15.0 22.5 32.0 30.5 22.3 0.06
VAS (at worst) 85.8 89.0 13.3 80.6 87.0 18.4 87.4 90.0 10.9 0.07
Roland Morris 
Questionnaire
17.8 19.0 4.8 18.0 19.0 4.6 17.7 19.0 4.8 0.68
Zung Depression Index 29.7 29.0 11.6 26.1 26.0 11.8 30.7 30.0 11.4 0.06
MSPQ Questionnaire 9.7 9.0 6.8 8.8 8.0 6.4 9.9 9.0 7.0 0.49
% Male 53.0 47.1 54.7 0.55
% Smoker 34.4 35.3 34.2 0.98
% Off work 50.0 44.1 51.7 0.33
% Previous spinal 
surgery
28.8 17.7 28.2 0.14
% traumatic onset 69.5 73.5 68.4 0.78
Notes: 1. p value refers to comparisons between included and excluded patients
* significant at p < 0.05
Table 2: Diagnostic value of clinical examination variables in relation to single anaesthetic zygapophysial joint block
Reference Standard A (75% reduction in Pain VAS)
N = 1161 Contingency table
Injection result
Positive Negative
Criteria satisfied 3 8
Criteria not satisfied 24 81
% Sn3 (95 CI8) % Sp4 (95 CI) % PPV5 (95 CI) % NPV6 (95 CI) + LR7 (95 CI)
11.1 (3.9,28.1) 91.0 (83.3,95.4) 27.3 (9.8,56.6) 77.1 (68.2,84.1) 1.2 (0.3,4.3)
Reference Standard B (Abolition of Primary Pain)
N = 1112 Contingency table
Injection result
Positive Negative
Criteria satisfied 3 6
Criteria not satisfied 15 84
% Sn (95 CI) % Sp (95 CI) % PPV (95 CI) % NPV (95 CI) + LR (95 CI)
16.7 (5.8,39.2) 93.3 (86.2,96.9) 33.3 (12.1,64.6) 84.9 (76.5,90.6) 2.5 (0.7,9.1)
Notes: 1n = 116. One case with missing data items. Unable to determine satisfaction of criteria
2n = 111. Cases with available data on abolition of primary pain
3Sn = sensitivity, Sp4 = specificity, PPV5 = positive predictive value, NPV6 = negative predictive value, +LR7 = positive likelihood ratio, 95 CI8 = 95% 
confidence intervalBMC Musculoskeletal Disorders 2004, 5:43 http://www.biomedcentral.com/1471-2474/5/43
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are presented in Table 2. With respect to reference stand-
ards A & B, sensitivities are low at 11 and 17%, specifici-
ties are high at 91 and 93% and likelihood ratios are 1.2
and 2.5 respectively.
Of the 27 patients satisfying reference standard A, 13
(48%) returned for confirmatory ZJ blocks. Three of these
reported 75% or more reduction in pain following the
confirmatory block. None of the three patients with con-
firmed ZJ pain satisfied Revel's criteria.
Discussion
The current data produces results that are in stark contrast
to those of Revel et al (1998) with sensitivity low and spe-
cificity high. However, 'no pain with cough and sneeze'
and 'no exacerbation of pain rising from flexion'
approached statistical significance in relation to a 75%
reduction pain after ZJ block (reference standard A). These
variables are in line with Revel's results. Age over 65 is
associated with reference standard B (abolition of primary
pain). Likelihood ratios for the criteria are lower in the
current data also. Some of the differences in results may
be explained by a number of factors:
1. Revel et al's study was a placebo controlled design
whereas we did not routinely utilize a similar or equiva-
lent control.
2. The patients in Revel et al's sample were older (mean 58
versus 43 years), and had a shorter duration of symptoms
(mean 78 versus 160 weeks).
3. It is also possible that the high level of standardization
when acquiring the criteria data in the current study, and
the prospective methodology might have contributed to
the differences in results.
Following anaesthetic blocks, patients frequently state
that the pain prompting consultation is abolished, yet a
post-procedure pain VAS still registers more than 0/100.
In this study reference standard B was evaluated as an
alternative to the usual standard, so that pain in areas
above the lumbar spine or pain directly attributable to the
needle insertion site do not result in inappropriate post
procedure VAS scores. In the interests of developing more
precise instruments documenting results of diagnostic
blocks, we propose that in future studies, the VAS scale
should specifically refer to the primary pain complaint for
which the diagnostic block is undertaken.
Based on the current data, Revel's criteria are not suitable
as a screening test to select patients suitable or unsuitable
for an initial screening ZJ block. Such a screening device
should have high sensitivity to ensure that most patients
likely to respond are included in the initial diagnostic
block. Our study suggests that, at best, Revel's criteria,
might identify a small subset (11%) of patients likely to
respond to a screening block (specificity 93%).
Conclusions
Neither strategy utilizing Revel's criteria is suitable as a
clinical screening device for selection of chronic LBP
patients for initial diagnostic ZJ blocks. In contrast to
Revel's findings, the current data demonstrated low sensi-
tivity and high specificity for these clinical criteria. The
high specificity of the criteria reported in this study relates
to a single uncontrolled screening block. Consequently
these criteria can not considered diagnostic of painful
lumbar ZJ. Only placebo controlled or double ZJ blocks
are able to diagnose this source of low back pain.
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